BioSpace News Archive

Biosion USA, Inc., a global clinical-stage R&D biotechnology company, announced that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for BSI-082, a novel anti-SIRPα monoclonal antibody candidate.

SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership.

Amphista Therapeutics (“the Company” or “Amphista”), a leader in next generation targeted protein degradation (TPD) approaches, today announces the achievement of two compelling new data sets with its next generation bifunctional degraders demonstrating in vivo efficacy and the ability to target and degrade proteins in the central nervous system (CNS).

Renexxion Ireland Limited announces U.S Food and Drug Administration (FDA) clearance of the Investigational New Drug (IND) application of naronapride for the treatment of patients with proton-pump inhibitor (PPI) non-responsive symptomatic gastroesophageal reflux disease.

Synnovation Therapeutics launched today with a $102 million Series A.

SciSparc Ltd. announced that it has entered into a standby equity purchase agreement with YA II PN, Ltd., a fund managed by Yorkville Advisors Global, LP.

Abbott today announced financial results for the fourth quarter ended Dec. 31, 2023.

Annovis Bio, Inc. has announced a postponement in the Phase III study data release for buntanetap in Parkinson’s Disease.

Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.

Pima Heart & Vascular proudly announces its leadership role in hosting the CardioVascular Interventions Summit (CVIS) 2024, set for February 16-17 at the El Conquistador Tucson, Arizona.